Linzagolix choline is a small-molecule, non-peptide, orally active gonadotropin-releasing hormone antagonist (GnRH antagonist) that potentially provides effective management of endometriosis-associated pain while mitigating bone mineral density loss and other adverse effects typically associated with currently approved treatments.
MedKoo Cat#: 561854
Name: Linzagolix
CAS#: 935283-04-8 (free)
Chemical Formula: C22H15F3N2O7S
Exact Mass: 508.0552
Molecular Weight: 508.42
Elemental Analysis: C, 51.97; H, 2.97; F, 11.21; N, 5.51; O, 22.03; S, 6.31
The following data is based on the product molecular weight 508.42 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
| 5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
| 10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
| 50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
